These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28643235)

  • 1. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
    Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
    Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
    Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
    J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
    Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
    J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
    Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
    Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
    Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
    Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
    Maiti B; Kamra M; Karande AA; Bhattacharya S
    Org Biomol Chem; 2018 Mar; 16(11):1983-1993. PubMed ID: 29498723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
    Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
    Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
    Narsineni L; Foldvari M
    Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgene expression in mice of the Opa1 mitochondrial transmembrane protein through bicontinuous cubic lipoplexes containing gemini imidazolium surfactants.
    Muñoz-Úbeda M; Semenzato M; Franco-Romero A; Junquera E; Aicart E; Scorrano L; López-Montero I
    J Nanobiotechnology; 2021 Dec; 19(1):425. PubMed ID: 34922554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
    Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
    J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.
    Sum CH; Nafissi N; Slavcev RA; Wettig S
    PLoS One; 2015; 10(11):e0142875. PubMed ID: 26561857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
    Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
    Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
    Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
    J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
    Ahmed T; Kamel AO; Wettig SD
    Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
    Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
    AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.
    Pietralik Z; Kumita JR; Dobson CM; Kozak M
    Colloids Surf B Biointerfaces; 2015 Jul; 131():83-92. PubMed ID: 25969417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between DNA and gemini surfactant: impact on gene therapy: part II.
    Ahmed T; Kamel AO; Wettig SD
    Nanomedicine (Lond); 2016 Feb; 11(4):403-20. PubMed ID: 26784450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
    Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
    Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
    Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
    J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of heterocyclic-based head group modifications on the structure-activity relationship of tocopherol-based lipids for non-viral gene delivery.
    Gosangi M; Mujahid TY; Gopal V; Patri SV
    Org Biomol Chem; 2016 Jul; 14(28):6857-70. PubMed ID: 27348545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.